CCR4 antagonist (C021) administration diminishes hypersensitivity and enhances the analgesic potency of morphine and buprenorphine in mouse model of neuropathic pain
Authors: Bogacka J., Ciapala K., Pawlik K., Kwiatkowski K., Dobrogowski J., Przeklasa-Muszyńska A., Mika J.
Published in: Front. Immunol.
Publication type: article
Subject areas: Immunology and Microbiology; Medicine
SJR best quartile: Q1